SLM Q1 2026 Earnings EPS Surges Past Estimates as Credit Performance Drives Profitability AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs OSRH Q4 2025 Earnings EPS Misses Estimates by 5686 Shares Decline IVVD Q1 2026 Earnings WiderthanExpected Loss Amid Continued Pipeline Development BURU Q3 2023 Earnings PreRevenue Loss of 014 per Share as Strategic Developments Underway Brookfield Asset Management Inc BAM Q1 2026 Earnings Slight EPS Miss Amid Stable Operations